My Quote Request
No products added yet
6505-01-311-5202
20 Products
NDC55513-0144-10
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115202
NSN
6505-01-311-5202
NDC55513-0144-10
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115202
NSN
6505-01-311-5202
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10000 UNITS EPOETIN ALFA PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPOETIN ALFA INJECTION 10000UN/ML 1ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: BUFFERED; PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
EPOGEN
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115203
NSN
6505-01-311-5203
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4000 UNITS EPOETIN ALFA PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPOETIN ALFA INJECTION 4000UN/ML 1ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: BUFFERED; PRESSERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
EPOGEN INJECTION
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115203
NSN
6505-01-311-5203
EPOGEN INJECTION
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115203
NSN
6505-01-311-5203
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4000 UNITS EPOETIN ALFA PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPOETIN ALFA INJECTION 4000UN/ML 1ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: BUFFERED; PRESSERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC55513-0148-10
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115203
NSN
6505-01-311-5203
NDC55513-0148-10
EPOETIN ALFA INJECTION
NSN, MFG P/N
6505013115203
NSN
6505-01-311-5203
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4000 UNITS EPOETIN ALFA PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPOETIN ALFA INJECTION 4000UN/ML 1ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: BUFFERED; PRESSERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00536-4644-05
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013117208
NSN
6505-01-311-7208
NDC00536-4644-05
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013117208
NSN
6505-01-311-7208
MFG
RUGBY GROUP INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ALUPENT
METAPROTERENOL SULFATE INHALATION AEROSOL,USP
NSN, MFG P/N
6505013118441
NSN
6505-01-311-8441
ALUPENT
METAPROTERENOL SULFATE INHALATION AEROSOL,USP
NSN, MFG P/N
6505013118441
NSN
6505-01-311-8441
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS METAPROTERENOL SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE INHALATION AEROSOL USP 15MG/ML 10ML PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: MICRONIZED; SHALL DELIVER AT LEAST 200 SINGLE ORAL INHALATIONS OF APPROXIMATELY 0.65 MG OF ACTIVE INGREDIENT PER METERED DOSE; PACKAGED W/PLASTIC MOUTHPIECE W/BUILT-IN NEBULIZER AND PROTECTIVE CAP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00597-0070-17
METAPROTERENOL SULFATE INHALATION AEROSOL,USP
NSN, MFG P/N
6505013118441
NSN
6505-01-311-8441
NDC00597-0070-17
METAPROTERENOL SULFATE INHALATION AEROSOL,USP
NSN, MFG P/N
6505013118441
NSN
6505-01-311-8441
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS METAPROTERENOL SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE INHALATION AEROSOL USP 15MG/ML 10ML PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: MICRONIZED; SHALL DELIVER AT LEAST 200 SINGLE ORAL INHALATIONS OF APPROXIMATELY 0.65 MG OF ACTIVE INGREDIENT PER METERED DOSE; PACKAGED W/PLASTIC MOUTHPIECE W/BUILT-IN NEBULIZER AND PROTECTIVE CAP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
CARPUJECT
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505013120375
NSN
6505-01-312-0375
CARPUJECT
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505013120375
NSN
6505-01-312-0375
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 USP UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE-NEEDLE UNIT
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: FOR INJECTION INTO INDWELLING VENIPUNCTURE DEVICE; NEEDLE SIZE 25 GAGE BY 5/8 INCH; PARTIAL FILL 2 ML. CARTRIDGE
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
H-732
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505013120375
NSN
6505-01-312-0375
H-732
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505013120375
NSN
6505-01-312-0375
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 USP UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE-NEEDLE UNIT
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: FOR INJECTION INTO INDWELLING VENIPUNCTURE DEVICE; NEEDLE SIZE 25 GAGE BY 5/8 INCH; PARTIAL FILL 2 ML. CARTRIDGE
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
NDC00024-0722-13
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505013120375
NSN
6505-01-312-0375
NDC00024-0722-13
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505013120375
NSN
6505-01-312-0375
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 USP UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE-NEEDLE UNIT
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: FOR INJECTION INTO INDWELLING VENIPUNCTURE DEVICE; NEEDLE SIZE 25 GAGE BY 5/8 INCH; PARTIAL FILL 2 ML. CARTRIDGE
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
K6025-07
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
NDC00015-7981-18
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
NDC00015-7981-18
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
PROSTAPHLIN
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
PROSTAPHLIN
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
PROSTAPHLIN ADD-VANTAGE
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
PROSTAPHLIN ADD-VANTAGE
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120907
NSN
6505-01-312-0907
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
NDC00015-7970-18
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120908
NSN
6505-01-312-0908
NDC00015-7970-18
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120908
NSN
6505-01-312-0908
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
PROSTAPHLIN
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120908
NSN
6505-01-312-0908
PROSTAPHLIN
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120908
NSN
6505-01-312-0908
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
PROSTAPHLIN ADD-VANTAGE
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120908
NSN
6505-01-312-0908
PROSTAPHLIN ADD-VANTAGE
OXACILLIN FOR INJECTION,USP
NSN, MFG P/N
6505013120908
NSN
6505-01-312-0908
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS OXACILLIN EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXACILLIN SODIUM FOR INJECTION USP 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW,ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
7279
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505013120910
NSN
6505-01-312-0910
MFG
LILLY ELI AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 GRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715; EACH VIAL SHALL BE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ENCLOSED IN AN UPPER AND LOWER SHROUD
Related Searches:
KEFUROX
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505013120910
NSN
6505-01-312-0910
MFG
DISTA PRODUCTS CO DIV OF LILLY ELI AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 GRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715; EACH VIAL SHALL BE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ENCLOSED IN AN UPPER AND LOWER SHROUD
Related Searches:
NDC00002-7279-10
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505013120910
NSN
6505-01-312-0910
NDC00002-7279-10
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505013120910
NSN
6505-01-312-0910
MFG
DISTA PRODUCTS CO DIV OF LILLY ELI AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 GRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715; EACH VIAL SHALL BE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ENCLOSED IN AN UPPER AND LOWER SHROUD
